The unlisted shares of Rubicon Research and Canara Robeco Asset Management are trading at a premium, indicating favorable listing gains when the IPOs debut on the market this week.
The initial public offerings (IPOs) of Canara Robeco Asset Management Company and Rubicon Research concluded their 3-day subscription on October 13. The IPO of Rubicon Research was oversubscribed 103.90 times, whereas the IPO of Canara Robeco was oversubscribed 9.74 times.
The demand for both these mainboard IPOs was led by Qualified Institutional Buyers. Investors can expect a potential listing gain from 4% up to 26% when the shares list on the stock market this week.
The grey market premium (GMP) for the IPOs continues to be in the news as private market investors continue to trade the unlisted shares on the grey market.
The GMP for the Rubicon Research IPO was Rs 127 as of 11:00 a.m.
Author's summary: IPOs of Rubicon Research and Canara Robeco show favorable listing gains.